Free shipping on all orders over $ 500


Cat. No. M3675
Rotigotine Structure
Size Price Availability
10mM*1mL USD 85.5  USD95 4-7 Days
10mg USD 78.3  USD87 4-7 Days
50mg USD 279  USD310 4-7 Days
100mg USD 396  USD440 4-7 Days
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control
  • Current batch:
  • Purity >98%
  • COA
  • MSDS
Biological Activity

Rotigotine is a nonergoline dopamine receptor agonist with structural similarity to dopamine. Rotigotine binds to the D1 through D5 dopamine receptors, having several times more affinity than dopamine does to the D2 and D3 receptors. Rotigotine's high lipid solubility and extended duration of action when applied to the skin in experimental models of PD suggested that rotigotine was a candidate for transdermal application.Randomized clinical studies also have demonstrated the efficacy of rotigotine in improving the symptoms of moderate-to-severe primary RLS.Rotigotine provides minor protection against MPP⁺ and rescues a significant number of THir neurons against rotenone in primary mesencephalic cell cultures relevant to PD.

Customer Product Validations & Biological Datas
Source Bioanalysis (2014). Figure 3. Rotigotine
Method competition binding assays
Cell Lines LMtk cells
Concentrations 10 μM
Incubation Time
Results There was a good correlation between functional potency of the agonists examined (Table 4) and their binding affinity versus [3H]rotigotine (Table 5) at the three dopamine receptors
Source Bioanalysis (2014). Figure 2. Rotigotine
Method competition binding assays
Cell Lines CHO cells
Concentrations 10 μM
Incubation Time
Results Equilibrium saturation assays were performed in triplicate with [3H]rotigotine and with the radiolabelled antagonist [3H]SCH23390 for D1 and D5, [3H]raclopride for D2 and [3H]spiperone for D3 and D4 receptors
Cell Experiment
Cell lines primary mesencephalic cell
Preparation method To investigate the effect of rotigotine (UCB, Belgium) on the survival of THir neurons, primary mesencephalic cell cultures were treated with different concentrations of rotigotine (0.01, 0.1, 1 and 10 µM) from the 6th DIV for 8 consecutive days. Rotigotine was added with each change of the culture medium every second day from a fresh stock solution (10 mM) prepared in DMSO (0.1% final concentration). To investigate the effect of rotigotine against MPP+ or rotenone-induced cell death, rotigotine was added from the 6th DIV until the 14th DIV as described above and MPP+ (10 µM) or rotenone (20 nM) were co-administered on the 12th DIV for 48 h.
Concentrations 0.01, 0.1, 1 and 10 μM
Incubation time 48 h
Animal Experiment
Animal models Sprague-Dawley rats
Formulation 1:10 ratio of dimethyl sulfoxide (DMSO) and 5% dextrose
Dosages 0.5 or 3 mg/kg
Administration s.c.
Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

Chemical Information
Molecular Weight 315.47
Formula C19H25NOS
CAS Number 99755-59-6
Purity >98%
Solubility DMSO 10 mM
Storage at -20°C

Rotigotine transdermal system: developing continuous dopaminergic delivery to treat Parkinson's disease and restless legs syndrome.
Benitez A, et al. Ann N Y Acad Sci. 2014 Aug 21. PMID: 25145951.

Neuroprotective effect of rotigotine against complex I inhibitors, MPP⁺ and rotenone, in primary mesencephalic cell culture.
Radad K, et al. Folia Neuropathol. 2014;52(2):179-86. PMID: 25118903.

Related Dopamine Receptor Products

ML417 is a highly selective and brain penetrant D3 dopamine receptor (D3R) agonist, with EC50 of 38 nM.


Cariprazine is a D2 and D3 receptor partial agonist, with high selectivity towards the D3 receptor.

PD-168077 maleate

PD-168077 maleate is a potent D4 dopamine receptor agonist (Ki = 8.7 nM), with > 400-fold and > 300-fold selectivity over D2 / D3 subtypes, respectively.


SCH23390 is a potent dopamine receptor antagonist (Ki values are 0.2 nM and 0.3 nM at D1 and D5 receptor sub-types, respectively).


MPTP hcl is a compound to the neurotoxin MPP+ which causes permanent symptoms of Parkinson's disease.

Abmole Inhibitor Catalog 2017

Keywords: Rotigotine supplier, Dopamine Receptor, inhibitors

Contact Us

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2020 AbMole BioScience. All Rights Reserved.